Brendan Reardon
Brendan Reardon
Dana-Farber Cancer Institute, Broad Institute of MIT & Harvard
بريد إلكتروني تم التحقق منه على dfci.harvard.edu
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
6112018
Integrated genomic characterization of pancreatic ductal adenocarcinoma
BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ...
Cancer cell 32 (2), 185-203. e13, 2017
4402017
AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie Consortium
Cancer discovery 7 (8), 818-831, 2017
2242017
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine
A Garofalo, L Sholl, B Reardon, A Taylor-Weiner, A Amin-Mansour, ...
Genome medicine 8 (1), 1-10, 2016
1022016
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
D Liu, P Abbosh, D Keliher, B Reardon, D Miao, K Mouw, A Weiner-Taylor, ...
Nature communications 8 (1), 1-11, 2017
492017
Inherited DNA-repair defects in colorectal cancer
SH AlDubayan, M Giannakis, ND Moore, GC Han, B Reardon, T Hamada, ...
The American Journal of Human Genetics 102 (3), 401-414, 2018
402018
Transverse Faraday-rotation gradients across the jets of 15 active galactic nuclei
DC Gabuzda, S Knuettel, B Reardon
Monthly Notices of the Royal Astronomical Society 450 (3), 2441-2450, 2015
392015
Genomic evolution after chemoradiotherapy in anal squamous cell carcinoma
KW Mouw, JM Cleary, B Reardon, J Pike, LZ Braunstein, J Kim, ...
Clinical Cancer Research 23 (12), 3214-3222, 2017
212017
Association of inherited pathogenic variants in checkpoint kinase 2 (CHEK2) with susceptibility to testicular germ cell tumors
SH AlDubayan, LC Pyle, M Gamulin, T Kulis, ND Moore, A Taylor-Weiner, ...
JAMA oncology 5 (4), 514-522, 2019
142019
Integrative molecular characterization of resistance to neoadjuvant chemoradiation in rectal cancer
SC Kamran, JK Lennerz, CA Margolis, D Liu, B Reardon, SA Wankowicz, ...
Clinical Cancer Research 25 (18), 5561-5571, 2019
82019
Identification of cancer driver genes based on nucleotide context
F Dietlein, D Weghorn, A Taylor-Weiner, A Richters, B Reardon, D Liu, ...
Nature Genetics 52 (2), 208-218, 2020
72020
I’m allergic to stupid decisions”: An m-Health campaign to reduce youth alcohol consumption
LS Suggs, G Rots, J Jacques, H Vong, J Mui, B Reardon
Cases Public Health Commun Mark 5, 111-35, 2011
52011
The role of clonal hematopoiesis of indeterminate potential (CHIP) in multiple myeloma: immunomodulator maintenance post autologous stem cell transplant (ASCT) predicts better …
TH Mouhieddine, J Park, RA Redd, CJ Gibson, S Manier, AH Nassar, ...
Blood 132 (Supplement 1), 749-749, 2018
42018
Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors
GJ Hanna, ER Kofman, MA Shazib, S Woo, B Reardon, NS Treister, ...
Oral oncology 81, 1-9, 2018
42018
Subclonal mutational heterogeneity and survival in cisplatin-resistant muscle-invasive bladder cancer.
D Liu, P Abbosh, D Keliher, B Reardon, KW Mouw, A Taylor-Weiner, ...
Journal of Clinical Oncology 35 (15_suppl), 4512-4512, 2017
32017
Genomic evolution and acquired resistance to pre-operative chemoradiation therapy in locally advanced rectal cancer
SC Kamran, JK Lennerz, B Reardon, SA Mullane, JY Wo, H Willers, ...
International Journal of Radiation Oncology• Biology• Physics 99 (2), S22-S23, 2017
22017
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
TH Mouhieddine, AS Sperling, R Redd, J Park, M Leventhal, CJ Gibson, ...
Nature Communications 11 (1), 1-9, 2020
12020
Immunomodulator maintenance post autologous stem cell transplant predicts better outcome in multiple myeloma patients with clonal hematopoiesis of indeterminate potential
TH Mouhieddine, J Park, R Redd, CJ Gibson, S Manier, A Nassar, ...
Cancer Research 78 (13 Supplement), 2954-2954, 2018
12018
Genomic evolution and acquired resistance to preoperative chemoradiation therapy (CRT) in rectal cancer.
SC Kamran, JK Lennerz, C Margolis, D Liu, B Reardon, SA Wankowicz, ...
Journal of Clinical Oncology 36 (4_suppl), 613-613, 2018
12018
Computational analysis of clinically actionable genomic features: precision heuristics for interpreting the alteration landscape (PHIAL)
B Reardon, N Moore, E VanAllen
Cancer Research 77 (13 Supplement), 558-558, 2017
12017
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20